🔗 Share this article Social Media Influencers Driving Parallel Market for Unapproved Slimming Medication A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on new investigations. Experimental Treatment Gaining Traction Online The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers. Thriving Commerce on Social Networks Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions. Learning About The Experimental Drug This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic. Medical Professionals Express Concerns Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in individuals administering substances of unknown origin. Some professionals said the popularity for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro. Legal Status and Enforcement Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations. Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison. Service Response and Material Elimination Based on the social media company, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies. Digital Trading Operations Investigations also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, populated with photos of slimming results, glowing reviews and detailed guides for mixing or administering at residence. After minutes of joining one community, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage. Item Details and Costs Inside these communities, posts display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.” Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”. Service Moderation and Security Actions A representative for the messaging service stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”. Medical Expert Warnings “Individuals are administering substances they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U. A medical professional of Asda Online Doctor connected the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained. Her staff has already seen individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.” Manufacturer Position A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially serious health risks”.